Predicting coronary heart disease risk using multiple lipid measures

American Journal of Cardiology

Volumn 95, Issue 8, 2005, Pages 986-988

  Everett, Charles J ^a   Mainous III, Arch G ^a   Koopman, Richelle J ^a   Diaz, Vanessa A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 16844366059     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.12.043     Document Type: Article

References (12)

1. T.R. Pedersen Pro and con: low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management Am J Cardiol 87 suppl 2001 8B 12B
2. G. Assmann Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management Am J Cardiol 87 suppl 2001 2B 7B
3. A.D. Sniderman, C.D. Furberg, A. Keech, J.E.R. Van Lennep, J. Frohlich, I. Jungner, G. Walldius Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment Lancet 361 2003 777 780
4. A.D. Sniderman, A.C. St-Pierre, B. Cantin, G.R. Dagenais, J.P. Despres, B. Lamarche Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk Am J Cardiol 91 2003 1173 1177
5. Dunteman GH. Principal Components Analysis. Sage University Paper Series on Quantitative Applications in the Social Sciences (No. 07-069). Newbury Park, CA: Sage Publications, 1989:1-96.
6. W.B. Kannel, M. Feinleib, P.M. McNamara, R.J. Garrison, W.P. Castelli An investigation of coronary heart disease in families: the Framingham Offspring Study Am J Epidemiol 110 1979 281 290
7. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol Clin Chem 28 1982 1379 1388
8. J.R. McNamara, E.J. Schaefer Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions Clin Chim Acta 166 1987 1 8
9. E.J. Schaefer, S. Lamon-Fava, J.M. Ordovas, S.D. Cohn, M.M. Schaefer, W.P. Castelli, P.W.F. Wilson Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study J Lipid Res 35 1994 871 882
10. E.J. Schaefer, S. Lamon-Fava, S.D. Cohn, M.M. Schaefer, J.M. Ordovas, W.P. Castelli, P.W.F. Wilson Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study J Lipid Res 35 1994 779 792
11. Kannel WB, Wolf PA, Garrison RJ. Monograph. Section 34: Some Risk Factors Related to the Annual Incidence of Cardiovascular Disease and Death Using Pooled Repeated Biennial Measurements: Framingham Heart Study, 30-Year Follow-Up. Springfield, MA: National Technical Information Service, 1987:1-459.
12. NCEP Expert Panel Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497